a nonsignificant trendp = 0.081
There was also a nonsignificant trend for higher LSN2463359 doses to reduce FAR (dose: F [3,45] = 2.395, p = 0.081; dose × group: F [3,45] = 0.159, p = 0.923).
There was also a nonsignificant trend for higher LSN2463359 doses to reduce FAR (dose: F [3,45] = 2.395, p = 0.081; dose × group: F [3,45] = 0.159, p = 0.923).
Donepezil (0.1–1 mg/kg) showed near-significant enhancements in d ′, and EVP-6124 (0.3–3 mg/kg) exerted no effects in the rCPT paradigm.